We are live on ! Find out more
XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

125 hedge funds and large institutions have $1.21B invested in Acceleron Pharma in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 10

100% more capital invested

Capital invested by funds: $607M → $1.21B (+$606M)

53% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 32

13% more funds holding

Funds holding: 111 → 125 (+14)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

49% less call options, than puts

Call options by funds: $9.66M | Put options by funds: $19.1M

Holders
125
Holders Change
+14
Holders Change %
+12.61%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
26
Increased
49
Reduced
32
Closed
10
Calls
$9.66M
Puts
$19.1M
Net Calls
-$9.42M
Net Calls Change
-$5.73M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$19.9M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$18.3M
3
DM
Deerfield Management
New York
+$7.68M
4
State Street
State Street
Massachusetts
+$6.54M
5
GIM
Granahan Investment Management
Massachusetts
+$5.97M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$19.1M
2
QF
QVT Financial
New York
-$7.97M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.04M
4
Citadel Advisors
Citadel Advisors
Florida
-$3.3M
5
NLVP
New Leaf Venture Partners
New York
-$2.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$2.11M +$260K +7,212 +20%
HLA
52
Hamilton Lane Advisors
Pennsylvania
$2.04M -$20.5K -571 -1%
D.E. Shaw & Co
53
D.E. Shaw & Co
New York
$1.97M +$1.46M +40,440 New
California State Teachers Retirement System (CalSTRS)
54
California State Teachers Retirement System (CalSTRS)
California
$1.96M +$23.1K +642 +2%
Thrivent Financial for Lutherans
55
Thrivent Financial for Lutherans
Minnesota
$1.83M +$259K +7,210 +24%
American Century Companies
56
American Century Companies
Missouri
$1.8M -$3.85K -107 -0.3%
EWM
57
Evercore Wealth Management
New York
$1.71M +$1.2M +33,375 +2,002%
TA
58
Teachers Advisors
New York
$1.56M +$21.8K +606 +2%
Norges Bank
59
Norges Bank
Norway
$1.46M – – –
ProShare Advisors
60
ProShare Advisors
Maryland
$1.46M +$94.2K +2,619 +10%
BlackRock
61
BlackRock
New York
$1.4M -$169K -4,700 -14%
BBA
62
Baker Bros. Advisors
New York
$1.4M – – –
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$1.26M – – –
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.25M – – –
PP
65
PDT Partners
New York
$1.23M +$909K +25,270 New
MIG
66
Mariner Investment Group
New York
$1.21M – – –
Wells Fargo
67
Wells Fargo
California
$1.18M +$639K +17,758 +273%
AllianceBernstein
68
AllianceBernstein
Tennessee
$1.18M -$118K -3,270 -12%
WMSA
69
Weiss Multi-Strategy Advisers
New York
$1.1M -$90K -2,500 -10%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$1.07M +$43.2K +1,200 +6%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$1.01M +$53.1K +1,475 +8%
State of New Jersey Common Pension Fund D
72
State of New Jersey Common Pension Fund D
New Jersey
$878K – – –
State Board of Administration of Florida Retirement System
73
State Board of Administration of Florida Retirement System
Florida
$872K +$5.04K +140 +0.8%
DekaBank Deutsche Girozentrale
74
DekaBank Deutsche Girozentrale
Germany
$833K +$10.8K +300 +2%
CWG
75
C WorldWide Group
Denmark
$800K -$52.5K -1,460 -8%
1 2
3
4 5

XLRN Hedge Fund Activity: Q4 2015 in Review

125 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Acceleron Pharma (XLRN) for Q4 2015, worth a combined $1.21B — up 100% from $607M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new XLRN positions and 10 closed out — a net gain of 16 holders — while 49 added to existing stakes and 32 trimmed.

The largest buyer was Millennium Management, adding an estimated $19.9M. The largest seller was Adage Capital Partners, cutting an estimated $19.1M.

  • 125 institutional investors held Acceleron Pharma (XLRN) as of Q4 2015, up from 111 in Q3 2015.
  • Funds reported $1.21B of Acceleron Pharma stock for Q4 2015, up 100% quarter-over-quarter.
  • 26 funds opened new Acceleron Pharma positions in Q4 2015 and 10 closed out, a net change of +16 holders.
  • The largest Acceleron Pharma buyer in Q4 2015 was Millennium Management, an estimated $19.9M added.
  • The largest Acceleron Pharma seller in Q4 2015 was Adage Capital Partners, an estimated $19.1M sold.

Based on aggregated 13F filings for Q4 2015.